Sysmex Corporation (SSMXY)
USD 18.76
(-0.27%)
USD 18.76
(-0.27%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 242.49 Billion JPY | 12.22% |
| 2023 | 216.08 Billion JPY | 13.38% |
| 2022 | 190.58 Billion JPY | 23.51% |
| 2021 | 154.3 Billion JPY | -3.44% |
| 2020 | 159.8 Billion JPY | -1.11% |
| 2019 | 161.6 Billion JPY | 1.67% |
| 2018 | 158.94 Billion JPY | 12.11% |
| 2017 | 141.77 Billion JPY | -5.91% |
| 2016 | 150.69 Billion JPY | 19.58% |
| 2015 | 126.01 Billion JPY | 8.9% |
| 2014 | 115.72 Billion JPY | 30.03% |
| 2013 | 88.99 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 50.4 Billion JPY | -17.66% |
| 2024 Q2 | 60.6 Billion JPY | 20.23% |
| 2024 Q3 | 60.75 Billion JPY | 0.25% |
| 2024 FY | 242.49 Billion JPY | 12.22% |
| 2024 Q4 | 70.72 Billion JPY | 16.4% |
| 2023 Q2 | 55.57 Billion JPY | 29.36% |
| 2023 FY | 216.08 Billion JPY | 13.38% |
| 2023 Q4 | 61.21 Billion JPY | 8.68% |
| 2023 Q3 | 56.32 Billion JPY | 1.35% |
| 2023 Q1 | 42.96 Billion JPY | -19.26% |
| 2022 Q3 | 47.55 Billion JPY | -0.79% |
| 2022 Q2 | 47.93 Billion JPY | 14.44% |
| 2022 FY | 190.58 Billion JPY | 23.51% |
| 2022 Q1 | 41.88 Billion JPY | -8.34% |
| 2022 Q4 | 53.2 Billion JPY | 11.88% |
| 2021 Q2 | 36.66 Billion JPY | 19.73% |
| 2021 FY | 154.3 Billion JPY | -3.44% |
| 2021 Q3 | 41.31 Billion JPY | 12.69% |
| 2021 Q1 | 30.62 Billion JPY | -27.26% |
| 2021 Q4 | 45.69 Billion JPY | 10.61% |
| 2020 Q4 | 42.09 Billion JPY | 4.79% |
| 2020 FY | 159.8 Billion JPY | -1.11% |
| 2020 Q3 | 40.17 Billion JPY | -1.21% |
| 2020 Q2 | 40.66 Billion JPY | 10.3% |
| 2020 Q1 | 36.87 Billion JPY | -19.5% |
| 2019 Q3 | 39.27 Billion JPY | 0.98% |
| 2019 FY | 161.6 Billion JPY | 1.67% |
| 2019 Q1 | 37.63 Billion JPY | -14.01% |
| 2019 Q2 | 38.89 Billion JPY | 3.33% |
| 2019 Q4 | 45.8 Billion JPY | 16.62% |
| 2018 Q3 | 40.66 Billion JPY | 2.59% |
| 2018 FY | 158.94 Billion JPY | 12.11% |
| 2018 Q1 | 34.87 Billion JPY | -6.32% |
| 2018 Q4 | 43.77 Billion JPY | 7.63% |
| 2018 Q2 | 39.64 Billion JPY | 13.68% |
| 2017 Q2 | 35.49 Billion JPY | 3.12% |
| 2017 Q3 | 34.64 Billion JPY | -2.37% |
| 2017 Q4 | 37.22 Billion JPY | 7.44% |
| 2017 FY | 141.77 Billion JPY | -5.91% |
| 2017 Q1 | 34.41 Billion JPY | -12.78% |
| 2016 FY | 150.69 Billion JPY | 19.58% |
| 2016 Q3 | 39.01 Billion JPY | 0.85% |
| 2016 Q2 | 38.69 Billion JPY | 14.03% |
| 2016 Q1 | 33.92 Billion JPY | -3.54% |
| 2016 Q4 | 39.45 Billion JPY | 1.13% |
| 2015 Q1 | 27.85 Billion JPY | -15.64% |
| 2015 Q4 | 35.17 Billion JPY | 9.35% |
| 2015 Q3 | 32.16 Billion JPY | 4.37% |
| 2015 Q2 | 30.82 Billion JPY | 10.64% |
| 2015 FY | 126.01 Billion JPY | 8.9% |
| 2014 Q2 | 28.71 Billion JPY | 16.63% |
| 2014 FY | 115.72 Billion JPY | 30.03% |
| 2014 Q4 | 33.02 Billion JPY | 12.43% |
| 2014 Q3 | 29.37 Billion JPY | 2.28% |
| 2014 Q1 | 24.61 Billion JPY | -2.1% |
| 2013 Q3 | 21.46 Billion JPY | -3.96% |
| 2013 Q2 | 22.34 Billion JPY | 0.0% |
| 2013 FY | 88.99 Billion JPY | 0.0% |
| 2013 Q4 | 25.14 Billion JPY | 17.17% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -14271926.423% |
| Ansell Limited | 624.8 Million USD | -38711.94% |
| Ansell Limited | 624.8 Million USD | -38711.94% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | -212724.993% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -179554155.674% |
| Psykey, Inc. | 415.97 Thousand USD | -58295811.303% |
| ConvaTec Group Plc | 1.2 Billion USD | -20055.95% |
| ConvaTec Group Plc | 1.17 Billion USD | -20541.556% |
| Encision Inc. | 3.13 Million USD | -7732678.65% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -30540583.843% |
| LifePoint, Inc. | -71.35 Thousand USD | 339831653.575% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 185112313.74% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -46189804.762% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -40198991.572% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -40658595.787% |
| SmileDirectClub, Inc. | 275.84 Million USD | -87809.965% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | -26822.307% |
| SheerVision, Inc. | 2.17 Million USD | -11144529.67% |
| United Health Products, Inc. | -4857.00 USD | 4992732239.181% |
| Vasamed, Inc. | -69.38 Thousand USD | 349479837.13% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -90597778.676% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -460565500.547% |